Bayer Aktiengesellschaft BAYZF Stock
Bayer Aktiengesellschaft Price Chart
Bayer Aktiengesellschaft BAYZF Financial and Trading Overview
| Bayer Aktiengesellschaft stock price | 38.94 USD |
| Previous Close | 43.83 USD |
| Open | 40.61 USD |
| Bid | 40.61 USD x 70000 |
| Ask | 41.92 USD x 20000 |
| Day's Range | 40.61 - 40.61 USD |
| 52 Week Range | 28.29 - 58.33 USD |
| Volume | 500 USD |
| Avg. Volume | 1.29K USD |
| Market Cap | 39.9B USD |
| Beta (5Y Monthly) | 0.843 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.55 USD |
| Forward Dividend & Yield | 0.13 (0.30%) |
| Ex-Dividend Date | April 27, 2026 |
| 1y Target Est | N/A |
BAYZF Valuation Measures
| Enterprise Value | 73.31B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 4.62 |
| Price/Sales (ttm) | 0.88184077 |
| Price/Book (mrq) | 1.1887133 |
| Enterprise Value/Revenue | 1.62 |
| Enterprise Value/EBITDA | 7.217 |
Trading Information
Bayer Aktiengesellschaft Stock Price History
| Beta (5Y Monthly) | 0.843 |
| 52-Week Change | 44.79% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 58.33 USD |
| 52 Week Low | 28.29 USD |
| 50-Day Moving Average | 45.27 USD |
| 200-Day Moving Average | 41.07 USD |
BAYZF Share Statistics
| Avg. Volume (3 month) | 1.29K USD |
| Avg. Daily Volume (10-Days) | 290 USD |
| Shares Outstanding | 982.42M |
| Float | 982.42M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 57.96% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.11 |
| Trailing Annual Dividend Yield | 0.25% |
| 5 Year Average Dividend Yield | 286.00% |
| Payout Ratio | 1.6327001 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -4.76% |
| Operating Margin (ttm) | 26.31% |
| Gross Margin | 59.91% |
| EBITDA Margin | 22.45% |
Management Effectiveness
| Return on Assets (ttm) | 3.63% |
| Return on Equity (ttm) | -6.92% |
Income Statement
| Revenue (ttm) | 45.24B USD |
| Revenue Per Share (ttm) | 46.05 USD |
| Quarterly Revenue Growth (yoy) | -2.39% |
| Gross Profit (ttm) | 27.11B USD |
| EBITDA | 10.16B USD |
| Net Income Avi to Common (ttm) | -2156000000 USD |
| Diluted EPS (ttm) | -2.54 |
| Quarterly Earnings Growth (yoy) | 112.70% |
Balance Sheet
| Total Cash (mrq) | 6.66B USD |
| Total Cash Per Share (mrq) | 6.78 USD |
| Total Debt (mrq) | 38.89B USD |
| Total Debt/Equity (mrq) | 134.27 USD |
| Current Ratio (mrq) | 1.055 |
| Book Value Per Share (mrq) | 34.16299 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.15B USD |
| Levered Free Cash Flow (ttm) | 7.31B USD |
Profile of Bayer Aktiengesellschaft
| Country | United States |
| State | N/A |
| City | Leverkusen |
| Address | Kaiser-Wilhelm-Allee 1 |
| ZIP | 51368 |
| Phone | 49 214 30 1 |
| Website | https://www.bayer.com |
| Industry | Drug Manufacturers - General |
| Sector(s) | Healthcare |
| Full Time Employees | 87757 |
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
Q&A For Bayer Aktiengesellschaft Stock
What is a current BAYZF stock price?
Bayer Aktiengesellschaft BAYZF stock price today per share is 38.94 USD.
How to purchase Bayer Aktiengesellschaft stock?
You can buy BAYZF shares on the OTC Markets OTCQX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Bayer Aktiengesellschaft?
The stock symbol or ticker of Bayer Aktiengesellschaft is BAYZF.
Which industry does the Bayer Aktiengesellschaft company belong to?
The Bayer Aktiengesellschaft industry is Drug Manufacturers - General.
How many shares does Bayer Aktiengesellschaft have in circulation?
The max supply of Bayer Aktiengesellschaft shares is 982.42M.
What is Bayer Aktiengesellschaft Price to Earnings Ratio (PE Ratio)?
Bayer Aktiengesellschaft PE Ratio is now.
What was Bayer Aktiengesellschaft earnings per share over the trailing 12 months (TTM)?
Bayer Aktiengesellschaft EPS is -2.55 USD over the trailing 12 months.
Which sector does the Bayer Aktiengesellschaft company belong to?
The Bayer Aktiengesellschaft sector is Healthcare.


